ZimVie Shareholders Receive Final Payout as ARCHIMED Acquisition Concludes
Veröffentlicht: 03.11.2025 um 13:14 Uhr, Redaktion boerse-global.de
The publicly traded chapter of ZimVie Inc. has officially closed. The dental technology company completed its acquisition by healthcare-focused private equity firm ARCHIMED in a transaction valued at $730 million. ZimVie shares ceased trading on the NASDAQ exchange in October, with shareholders receiving a final cash distribution of $19 per share—a figure that nearly doubled the stock’s 90-day average price prior to the deal’s announcement.
In a special meeting held on October 10, ZimVie stockholders overwhelmingly voted to approve the acquisition. Trading was halted after the market closed on October 17, with NASDAQ formally suspending the listing on October 21. The transaction concluded on October 20, converting every outstanding share into a $19 cash payment.
This Read more...
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
